about
Clinical features of pediatric nonalcoholic fatty liver disease: a need for increased awareness and a consensus for screening.Should nonalcoholic fatty liver disease be renamed?Is liver disease a threat to patients with metabolic disorders?Review article: the treatment of non-alcoholic steatohepatitis with thiazolidinediones.Challenges and opportunities in drug and biomarker development for nonalcoholic steatohepatitis: findings and recommendations from an American Association for the Study of Liver Diseases-U.S. Food and Drug Administration Joint WorkshopEffect of lifestyle intervention on non-alcoholic fatty liver disease in Chinese obese children.Nonalcoholic Fatty Liver Disease: Clinical Features and Pathogenesis.Acute steatohepatitis, due to extreme metabolic dysregulation, as the first presentation of non-alcoholic fatty liver disease.Nonalcoholic steatohepatitis: risk factors and diagnosis.Aggressive non-alcoholic steatohepatitis following rapid weight loss and/or malnutrition.Combination of N-acetylcysteine and metformin improves histological steatosis and fibrosis in patients with non-alcoholic steatohepatitis.Refractory subacute steatohepatitis after biliopancreatic diversion.Major histocompatibility complex class I-related chains A and B (MIC A/B): a novel role in nonalcoholic steatohepatitis.Non-alcoholic steatohepatitis occurring in a patient with T-lymphoblastic lymphoma during chemotherapy including prednisolone.
P2860
Q26859406-5CE1A6CC-C18E-4CD7-B166-DF6482CFC1FEQ36141458-27296E39-FEE8-4A0E-A609-463986EFA6A0Q36265230-6A882DB5-7B3E-42E8-8EF9-6EA28FDEFA37Q36305927-C4332364-D7F1-4FCE-ACDF-E4F5BEEAB9E7Q36987260-E9E0FBF8-93A6-4279-BF5F-E13E096B6BA0Q37220903-755A19F9-D590-4968-ADBF-D0F1D9D26DD0Q37678998-39BAA009-0D34-4D7F-AF63-D51801CFEBB1Q37694201-3C3114B8-5383-4C3D-9DCB-421F7399E5D3Q37798824-3CDB545C-EB86-4DA9-B494-7DCFB41A73FAQ46776547-468509E4-9C21-4FA3-9B2F-FBACD2DA1F6DQ46806360-EB3C3945-E89B-492C-93FA-F7BA0339D0F9Q49125291-811B9972-4A09-4333-B2FC-98B5D885AEB4Q50590704-07CA396D-C1E6-420E-8C0D-0C82C183118BQ53523642-9ABEF5D2-0B93-481C-A50D-C124654A12D9
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
Subacute liver failure in obese women.
@ast
Subacute liver failure in obese women.
@en
type
label
Subacute liver failure in obese women.
@ast
Subacute liver failure in obese women.
@en
prefLabel
Subacute liver failure in obese women.
@ast
Subacute liver failure in obese women.
@en
P2860
P1476
Subacute liver failure in obese women.
@en
P2093
Elizabeth E Hespenheide
Stephen H Caldwell
P2860
P304
P356
10.1111/J.1572-0241.2002.05922.X
P407
P577
2002-08-01T00:00:00Z